Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis.
Eisen T; Ahmad T; Flaherty KT; Gore M; Kaye S; Marais R; Gibbens I; Hackett S; James M; Schuchter LM; Nathanson KL; Xia C; Simantov R; Schwartz B; Poulin-Costello M; O'Dwyer PJ; Ratain MJ; British Journal Of Cancer, 2006, vol. 95, issue 5, p 581, ISSN 00070920. ISBN 00070920.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef